Carregant...

Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer

Background: The prognostic factors for efficacy of poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer remain unknown. The purpose of this study is to evaluate the efficacy of PARP inhibitors and to explore their prognostic factors in ovarian cancer. Methods: PubMed, Embase, and conferen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Huang, Xuan-zhang, Jia, Han, Xiao, Qiong, Li, Run-zhou, Wang, Xing-shuang, Yin, Hai-yan, Zhou, Xin
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7308557/
https://ncbi.nlm.nih.gov/pubmed/32612955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00958
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!